These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36140265)
21. Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality. Lee CY; Ooi IH Pharmaceuticals (Basel); 2016 Sep; 9(3):. PubMed ID: 27618068 [TBL] [Abstract][Full Text] [Related]
22. Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide. Faustino AC; Viani GA; Hamamura AC Clinics (Sao Paulo); 2020; 75():e1553. PubMed ID: 32935821 [TBL] [Abstract][Full Text] [Related]
23. Nanotechnology for Treatment of Glioblastoma Multiforme. Michael JS; Lee BS; Zhang M; Yu JS J Transl Int Med; 2018 Sep; 6(3):128-133. PubMed ID: 30425948 [TBL] [Abstract][Full Text] [Related]
24. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703 [TBL] [Abstract][Full Text] [Related]
25. Liposomal temozolomide drug delivery using convection enhanced delivery. Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727 [TBL] [Abstract][Full Text] [Related]
26. Temozolomide resistance in glioblastoma multiforme. Lee SY Genes Dis; 2016 Sep; 3(3):198-210. PubMed ID: 30258889 [TBL] [Abstract][Full Text] [Related]
27. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma. Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758 [TBL] [Abstract][Full Text] [Related]
28. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522 [TBL] [Abstract][Full Text] [Related]
29. Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry. Braun K; Wiessler M; Ehemann V; Pipkorn R; Spring H; Debus J; Didinger B; Koch M; Muller G; Waldeck W Drug Des Devel Ther; 2009 Feb; 2():289-301. PubMed ID: 19920915 [TBL] [Abstract][Full Text] [Related]
30. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Yasaswi PS; Shetty K; Yadav KS J Control Release; 2021 Aug; 336():549-571. PubMed ID: 34229001 [TBL] [Abstract][Full Text] [Related]
31. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme. Gainer JL; Sheehan JP; Larner JM; Jones DR J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177 [TBL] [Abstract][Full Text] [Related]
32. Time trends in glioblastoma multiforme survival: the role of temozolomide. Dubrow R; Darefsky AS; Jacobs DI; Park LS; Rose MG; Laurans MS; King JT Neuro Oncol; 2013 Dec; 15(12):1750-61. PubMed ID: 24046259 [TBL] [Abstract][Full Text] [Related]
33. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
34. Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme. Liu SA; Sullivan T; Bryce C; Chan AM; Cilmi S BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154345 [TBL] [Abstract][Full Text] [Related]
35. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies. Fadera S; Chen PY; Liu HL; Lee IC ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925 [TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2. Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898 [TBL] [Abstract][Full Text] [Related]
37. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. Li Y; Liu Y; Ren J; Deng S; Yi G; Guo M; Shu S; Zhao L; Peng Y; Qi S J Neurooncol; 2018 Jul; 138(3):499-508. PubMed ID: 29876787 [TBL] [Abstract][Full Text] [Related]
38. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657 [TBL] [Abstract][Full Text] [Related]
39. Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging. Cho HR; Kumari N; Thakur N; Vu HT; Kim H; Choi SH Sci Rep; 2019 Nov; 9(1):16613. PubMed ID: 31719653 [TBL] [Abstract][Full Text] [Related]